Dr. Ritu Salani, a board-certified gynecologic oncologist and the Director of Gynecologic Oncology on the College of California, Los Angeles (UCLA), UCLA Well...
FDA approves Adcetris plus Revlimid and Rituxan relapsed or refractory giant B-cell lymphoma.The Meals and Drug Administration (FDA) has permitted Adcetris (brentuximab vedotin)...
On Jan. 27, the Meals and Drug Administration (FDA) granted approval to remedy with Enhertu (fam-trastuzumab deruxtecan-nxki) for sufferers with unresectable or metastatic...
The Decipher Bladder check could predict bladder most cancers upstaging and assist establish sufferers who may benefit from extra intensive remedy.For sufferers with...
